Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jun;35(6):1099–1107. doi: 10.1128/aac.35.6.1099

Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity.

C A Bell 1, M Cory 1, T A Fairley 1, J E Hall 1, R R Tidwell 1
PMCID: PMC284294  PMID: 1929249

Abstract

1,5-Di(4-amidinophenoxy)pentane (pentamidine) and 38 analogs of pentamidine were screened for in vitro activity against the enteric protozoan Giardia lamblia WB (ATCC 30957). All compounds were active against G. lamblia as measured by a [methyl-3H]thymidine incorporation assay. Antigiardial activity varied widely, with 50% inhibitory concentrations (IC50s) ranging from 0.51 +/- 0.13 microM (mean +/- standard deviation) for the most active compound to over 100.0 microM for the least active compounds. The IC50 of the most potent antigiardial agent, 1,3-di(4-amidino-2-methoxyphenoxy)propane compared favorably with the IC50s of the compounds currently used to treat giardiasis, i.e., furazolidone (1.0 +/- 0.03 microM), metronidazole (2.1 +/- 0.80 microM), quinacrine HCl (0.03 +/- 0.02 microM), and tinidazole (0.78 +/- 0.48 microM). A mode of antigiardial activity for these compounds was suggested by the correlation observed between antigiardial activity and the binding of the compounds to calf thymus DNA and poly(dA).poly(dT).

Full text

PDF
1099

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auran J. D., Starr M. B., Jakobiec F. A. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6(1):2–26. [PubMed] [Google Scholar]
  2. Bell C. A., Hall J. E., Kyle D. E., Grogl M., Ohemeng K. A., Allen M. A., Tidwell R. R. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob Agents Chemother. 1990 Jul;34(7):1381–1386. doi: 10.1128/aac.34.7.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boreham P. F., Phillips R. E., Shepherd R. W. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother. 1984 Nov;14(5):449–461. doi: 10.1093/jac/14.5.449. [DOI] [PubMed] [Google Scholar]
  4. Bryceson A. D., Chulay J. D., Mugambi M., Were J. B., Gachihi G., Chunge C. N., Muigai R., Bhatt S. M., Ho M., Spencer H. C. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans R Soc Trop Med Hyg. 1985;79(5):705–714. doi: 10.1016/0035-9203(85)90199-3. [DOI] [PubMed] [Google Scholar]
  5. Craft J. C., Murphy T., Nelson J. D. Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. Am J Dis Child. 1981 Feb;135(2):164–166. doi: 10.1001/archpedi.1981.02130260056016. [DOI] [PubMed] [Google Scholar]
  6. Croft S. L., Brazil R. P. Effect of pentamidine isethionate on the ultrastructure and morphology of Leishmania mexicana amazonensis in vitro. Ann Trop Med Parasitol. 1982 Feb;76(1):37–43. doi: 10.1080/00034983.1982.11687502. [DOI] [PubMed] [Google Scholar]
  7. Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drake S., Lampasona V., Nicks H. L., Schwarzmann S. W. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Clin Pharm. 1985 Sep-Oct;4(5):507–516. [PubMed] [Google Scholar]
  9. Fox K. R., Sansom C. E., Stevens M. F. Footprinting studies on the sequence-selective binding of pentamidine to DNA. FEBS Lett. 1990 Jun 18;266(1-2):150–154. doi: 10.1016/0014-5793(90)81527-u. [DOI] [PubMed] [Google Scholar]
  10. Francioli P. B., Keithly J. S., Jones T. C., Brandstetter R. D., Wolf D. J. Response of babesiosis to pentamidine therapy. Ann Intern Med. 1981 Mar;94(3):326–330. doi: 10.7326/0003-4819-94-3-326. [DOI] [PubMed] [Google Scholar]
  11. Geratz J. D., Whitmore A. C. Diamidino-alpha,omega-diphenoxyalkanes. Structure-activity relationships for the inhibition of thrombin, pancreatic kallikrein, and trypsin. J Med Chem. 1973 Sep;16(9):970–975. doi: 10.1021/jm00267a003. [DOI] [PubMed] [Google Scholar]
  12. Gutteridge W. E. Some effects of pentamidine di-isethionate on Crithidia fasciculata. J Protozool. 1969 May;16(2):306–311. doi: 10.1111/j.1550-7408.1969.tb02275.x. [DOI] [PubMed] [Google Scholar]
  13. Inge P. M., Farthing M. J. A radiometric assay for antigiardial drugs. Trans R Soc Trop Med Hyg. 1987;81(2):345–347. doi: 10.1016/0035-9203(87)90260-4. [DOI] [PubMed] [Google Scholar]
  14. Jokipii L., Jokipii A. M. In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole. J Infect Dis. 1980 Mar;141(3):317–325. doi: 10.1093/infdis/141.3.317. [DOI] [PubMed] [Google Scholar]
  15. Jones S. K., Hall J. E., Allen M. A., Morrison S. D., Ohemeng K. A., Reddy V. V., Geratz J. D., Tidwell R. R. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990 Jun;34(6):1026–1030. doi: 10.1128/aac.34.6.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Keister D. B. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg. 1983;77(4):487–488. doi: 10.1016/0035-9203(83)90120-7. [DOI] [PubMed] [Google Scholar]
  17. Larsen T. A., Goodsell D. S., Cascio D., Grzeskowiak K., Dickerson R. E. The structure of DAPI bound to DNA. J Biomol Struct Dyn. 1989 Dec;7(3):477–491. doi: 10.1080/07391102.1989.10508505. [DOI] [PubMed] [Google Scholar]
  18. Levi G. C., de Avila C. A., Amato Neto V. Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg. 1977 May;26(3):564–565. doi: 10.4269/ajtmh.1977.26.564. [DOI] [PubMed] [Google Scholar]
  19. Macadam R. F., Williamson J. Drug effects on the fine structure of Trypanosoma rhodesiense: diamidines. Trans R Soc Trop Med Hyg. 1972;66(6):897–904. doi: 10.1016/0035-9203(72)90125-3. [DOI] [PubMed] [Google Scholar]
  20. Manzini G., Barcellona M. L., Avitabile M., Quadrifoglio F. Interaction of diamidino-2-phenylindole (DAPI) with natural and synthetic nucleic acids. Nucleic Acids Res. 1983 Dec 20;11(24):8861–8876. doi: 10.1093/nar/11.24.8861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Montgomery A. B., Debs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. doi: 10.1016/s0140-6736(87)91794-6. [DOI] [PubMed] [Google Scholar]
  22. Oduola A. M., Weatherly N. F., Bowdre J. H., Desjardins R. E. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol. 1988 Jun;66(1):86–95. doi: 10.1016/0014-4894(88)90053-7. [DOI] [PubMed] [Google Scholar]
  23. Portugal J., Waring M. J. Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study. Eur J Biochem. 1987 Sep 1;167(2):281–289. doi: 10.1111/j.1432-1033.1987.tb13334.x. [DOI] [PubMed] [Google Scholar]
  24. Sands M., Kron M. A., Brown R. B. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625–634. doi: 10.1093/clinids/7.5.625. [DOI] [PubMed] [Google Scholar]
  25. Shapiro T. A., Englund P. T. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc Natl Acad Sci U S A. 1990 Feb;87(3):950–954. doi: 10.1073/pnas.87.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tidwell R. R., Jones S. K., Geratz J. D., Ohemeng K. A., Cory M., Hall J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J Med Chem. 1990 Apr;33(4):1252–1257. doi: 10.1021/jm00166a026. [DOI] [PubMed] [Google Scholar]
  27. Tidwell R. R., Kilgore S. G., Ohemeng K. A., Geratz J. D., Hall J. E. Treatment of experimental Pneumocystis carinii pneumonia with analogs of pentamidine. J Protozool. 1989 Jan-Feb;36(1):74S–76S. doi: 10.1111/j.1550-7408.1989.tb02711.x. [DOI] [PubMed] [Google Scholar]
  28. Vonderfecht S. L., Miskuff R. L., Wee S. B., Sato S., Tidwell R. R., Geratz J. D., Yolken R. H. Protease inhibitors suppress the in vitro and in vivo replication of rotavirus. J Clin Invest. 1988 Dec;82(6):2011–2016. doi: 10.1172/JCI113821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wallis O. C. The effect of pentamidine on ribosomes of the parasitic flagellate Crithidia (Strigomonas) oncopelti. J Protozool. 1966 May;13(2):234–239. doi: 10.1111/j.1550-7408.1966.tb01900.x. [DOI] [PubMed] [Google Scholar]
  30. Wolfe M. S. Giardiasis. JAMA. 1975 Sep 29;233(13):1362–1365. [PubMed] [Google Scholar]
  31. Woynarowski J. M., McHugh M., Sigmund R. D., Beerman T. A. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole. Mol Pharmacol. 1989 Feb;35(2):177–182. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES